Teladoc (Germany) Performance
4LL Stock | EUR 11.00 0.56 4.84% |
On a scale of 0 to 100, Teladoc holds a performance score of 16. The entity has a beta of 1.81, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Teladoc will likely underperform. Please check Teladoc's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether Teladoc's existing price patterns will revert.
Risk-Adjusted Performance
16 of 100
Weak | Strong |
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Teladoc are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Teladoc reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash Flow | 893.5 M |
Teladoc |
Teladoc Relative Risk vs. Return Landscape
If you would invest 635.00 in Teladoc on August 29, 2024 and sell it today you would earn a total of 465.00 from holding Teladoc or generate 73.23% return on investment over 90 days. Teladoc is currently producing 0.9479% returns and takes up 4.5456% volatility of returns over 90 trading days. Put another way, 40% of traded stocks are less volatile than Teladoc, and 82% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
Risk |
Teladoc Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Teladoc's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Teladoc, and traders can use it to determine the average amount a Teladoc's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2085
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 4LL | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
4.55 actual daily | 40 60% of assets are more volatile |
Expected Return
0.95 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
0.21 actual daily | 16 84% of assets perform better |
Based on monthly moving average Teladoc is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teladoc by adding it to a well-diversified portfolio.
Teladoc Fundamentals Growth
Teladoc Stock prices reflect investors' perceptions of the future prospects and financial health of Teladoc, and Teladoc fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Teladoc Stock performance.
Return On Equity | -1.49 | |||
Return On Asset | -0.0129 | |||
Operating Margin | (0.09) % | |||
Current Valuation | 5.01 B | |||
Shares Outstanding | 162.84 M | |||
Price To Book | 0.75 X | |||
Price To Sales | 1.77 X | |||
Revenue | 2.41 B | |||
EBITDA | 43.28 M | |||
Cash And Equivalents | 722.63 M | |||
Cash Per Share | 4.68 X | |||
Total Debt | 1.54 B | |||
Debt To Equity | 0.09 % | |||
Book Value Per Share | 14.17 X | |||
Cash Flow From Operations | 189.29 M | |||
Earnings Per Share | (53.10) X | |||
Total Asset | 4.35 B | |||
About Teladoc Performance
By analyzing Teladoc's fundamental ratios, stakeholders can gain valuable insights into Teladoc's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Teladoc has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Teladoc has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Teladoc Health, Inc. provides virtual healthcare services on a business-to-business basis in the United States and internationally. Teladoc Health, Inc. was Incorporated in 2002 and is headquartered in Purchase, New York. TELADOC HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3652 people.Things to note about Teladoc performance evaluation
Checking the ongoing alerts about Teladoc for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Teladoc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Teladoc appears to be risky and price may revert if volatility continues | |
The company reported the revenue of 2.41 B. Net Loss for the year was (13.66 B) with profit before overhead, payroll, taxes, and interest of 1.66 B. | |
Over 82.0% of the company shares are owned by institutions such as pension funds |
- Analyzing Teladoc's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Teladoc's stock is overvalued or undervalued compared to its peers.
- Examining Teladoc's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Teladoc's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Teladoc's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Teladoc's stock. These opinions can provide insight into Teladoc's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Teladoc Stock analysis
When running Teladoc's price analysis, check to measure Teladoc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teladoc is operating at the current time. Most of Teladoc's value examination focuses on studying past and present price action to predict the probability of Teladoc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teladoc's price. Additionally, you may evaluate how the addition of Teladoc to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |